Health Services Research
Latest posts by Health Services Research (see all)
- Hospital Postacute Care Referral Networks: Is Referral Concentration Associated with… - Dec. 05, 2016
- Physician Engagement Strategies in Care Coordination: Findings from the Centers for Medicare… - Dec. 02, 2016
- The Effect of Certificate of Need Laws on All-Cause Mortality - Dec. 02, 2016
- Are Two Heads Better Than One or Do Too Many Cooks Spoil the Broth? The Trade-Off between… - Nov. 28, 2016
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.